BACKGROUND: Pre-eclampsia is a disorder marked by hypertension during pregnancy that is a leading cause of maternal and infant morbidity, mortality, and premature births worldwide. Pre-eclampsia is thought to result from a poor placental perfusion of unclear causes. Gene expression profiles of placenta-associated genes have been shown to be altered in patients with pre-eclampsia, but the actual regulators remain unknown. We aimed to identify and analyze key regulatory genes associated with pre-eclampsia.METHODS: In this paper, we analyzed the gene expression profiles of placentas of women with first-trimester pre-eclampsia to identify key regulators; in addition, we performed protein-protein interaction, gene ontology (GO) enrichment, and pathway analyses.RESULTS: After applying log fold-change statistics, we found 231 differentially expressed genes (DEGs) between normal and pre-eclampsia placentas. We confirmed through downstream analyses that these genes are associated with CYP-mediated steroid metabolism and hydroxylation in pregnancy, with glucuronidation and hyperbilirubinemia, and with other biological pathways.CONCLUSIONS: The identified DEGs associated with pre-eclampsia may be targeted in studies to clarify the pathogenesis of this condition.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2021) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: